Patents Examined by Heather Calamita
-
Patent number: 11718847Abstract: Methods and compositions are provided for amplifying a pool of oligonucleotides, such as dual guide oligonucleotide constructs comprising sequences encoding a first guide RNA segment and a sequence encoding a second guide RNA segment. An amplification mixture is formed comprising the pool of oligonucleotides, an amplification enzyme, deoxyribonucleotide triphosphates, and primers. The amplification mixture is thermocycled a sufficient number of times and under conditions to produce a library of oligonucleotide constructs. The present methods and compositions provide dual guide libraries, including libraries that are essentially free of scrambled library members.Type: GrantFiled: August 29, 2018Date of Patent: August 8, 2023Assignee: Agilent Technologies, Inc.Inventors: Jeffrey Carl Braman, Peter James Sheffield, Holly Hogrefe
-
Patent number: 9599611Abstract: This disclosure provides methods and devices for the label-free detection of target molecules of interest. The principles of the disclosure are particularly applicable to the detection of biological molecules (e.g., DNA, RNA, and protein) using standard SiO2-based microarray technology.Type: GrantFiled: April 25, 2006Date of Patent: March 21, 2017Assignee: TRUSTEES OF BOSTON UNIVERSITYInventors: M. Selim Unlu, David A. Bergstein, Michael F. Ruane, Bennett B. Goldberg
-
Patent number: 9482666Abstract: The invention provides methods for identifying cell binding and/or lytic polypeptides that permit production of specific polypeptide therapeutics in a high throughput manner.Type: GrantFiled: November 1, 2012Date of Patent: November 1, 2016Assignee: Arizona Board of Regents, a Body Corporate of the State of Arizona, Acting for and on Behalf of Arizona State UniversityInventors: Valeriy Domenyuk, Chris Diehnelt, Stephen Johnston
-
Patent number: 9416359Abstract: Method and kit for constructing a random mutagenesis library. The method comprises providing a first expression vector comprising a target polynucleotide fragment, providing a pair of Vector-primers that are complementary to the vector portion of the first expression vector, wherein the Vector-primers comprise a second selection marker gene, and wherein the Vector-primers allow PCR amplification of the target polynucleotide; and performing a PCR reaction using the first expression vector as the template with the Vector-primers under error-prone PCR conditions in the presence of a thermostable DNA ligase, generating a second expression vector which comprises the second selection marker gene and a mutated target polynucleotide.Type: GrantFiled: March 15, 2010Date of Patent: August 16, 2016Inventors: Weilan Shao, Yilin Le, Jianjun Pei
-
Patent number: 9244057Abstract: The present invention relates to solution microarrays. In particular, the present invention relates to an aqueous 2-phase system for solution microarrays and uses thereof. Additional embodiments are described herein.Type: GrantFiled: March 18, 2011Date of Patent: January 26, 2016Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Shuichi Takayama, Hossein Tavana, Arlyne Simon
-
Patent number: 9068972Abstract: A reversion mutation assay that is unique in providing a quantitative readout for mutagenesis. This assay is based on the creation of a functional GFP-?-lactamase fusion protein as a reporter providing both antibiotic resistance and fluorescence. This dual reporter is placed in a multicopy plasmid to increase the number of targets, with a reversion site at the N-terminus. Rare mutations at the reversion site allow read-through of the fusion protein, producing both beta-lactamase (providing antibiotic resistance) and GFP (emitting fluorescence). In the presence of carbenicillin, beta-lactamase production confers a selective advantage that allows amplification of mutant plasmids, raising the level of fluorescence emitted by GFP to levels that are detectable by fluorimetry. A window of time can be found where fluorescence is proportional to the number of mutation events at the reversion site, making fluorescence a quantitative measure of mutagenesis.Type: GrantFiled: November 2, 2010Date of Patent: June 30, 2015Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Manel Camps, Jennifer Allen
-
Patent number: 9040462Abstract: The present invention relates to methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo. The prevent invention also relates to methods for inhibiting protein-protein interaction.Type: GrantFiled: May 12, 2008Date of Patent: May 26, 2015Assignee: Rigel Pharmaceuticals, Inc.Inventors: James B. Lorens, Todd R. Pray, Todd M. Kinsella, Mark K. Bennett
-
Patent number: 9006148Abstract: Methods of using a progressive cavity pump as a bioreactor are disclosed. Methods of isolating a biological product, such as pancreatic islet cells, using the bioreactor are also disclosed.Type: GrantFiled: September 13, 2012Date of Patent: April 14, 2015Inventor: Harvey Zar
-
Patent number: 8921278Abstract: A method is disclosed to obtain oligonucleotide sequences with high affinity to target molecules. By design, the oligonucleotides have a defined primary and secondary structure. The affinity for binding to target species is classified or quantified by assay measurements using physical measurements rather than being based primarily on separations. Targets include but are not limited to proteins, polymers, biological membranes including cells and organelles and small molecules.Type: GrantFiled: March 23, 2006Date of Patent: December 30, 2014Assignee: Syracuse UniversityInventors: Bruce S. Hudson, Philip N. Borer
-
Patent number: 8912127Abstract: The invention relates to a method for generating a gene mosaic by somatic in vivo recombination, comprising: e) in a single step procedure (vii) transforming a cell with at least one gene A having a sequence homology of less than 99.5% to another gene to be recombined that is an integral part of the cell genome or presented in the framework of a genetic construct, (viii) recombining said genes, (ix) generating a gene mosaic of the genes at an integration site of a target genome, wherein said at least one gene A has a single flanking target sequence either at the 5? end or 3? end anchoring to the 5? or 3? end of said integration site, and f) selecting clones comprising the gene mosaic, as well as a method of producing a diversity of gene mosaics and gene assembly.Type: GrantFiled: April 8, 2011Date of Patent: December 16, 2014Assignee: Eviagenics, S.A.Inventors: Rudy Pandjaitan, Alejandro Luque
-
Patent number: 8911949Abstract: Embodiments of the present disclosure generally pertain to systems and methods for performing amplicon rescue multiplex polymerase chain reaction (arm-PCR). In one embodiment, the system comprises a processor and a reader coupled to a control element. The control element is configured to control the operation of the processor and the reader based on a variety of settings. The processor is configured to receive a self-contained cassette for performing PCR amplification of DNA and/or RNA obtained from an organic specimen. The processor engages with the cassette and manipulates reagents within the cassette in order to amplify and detect the DNA from the specimen. The processor also causes the cassette to deposit the DNA on a microarray within the cassette. The reader is configured to receive the cassette after it has been processed by the processor and to capture an image of the microarray for transmission to the control element as test data.Type: GrantFiled: November 12, 2012Date of Patent: December 16, 2014Assignee: iCubate, Inc.Inventors: Jeff Bertrand, Jian Han
-
Patent number: 8883811Abstract: A fungicidal composition containing a fungicidally effective amount of a compound of Formula I-V and at least one fungicide selected from the group consisting of epoxiconazole, prothioconazole, azoxystrobin, pyraclostrobin, penthiopyrad, isopyrazam, bixafen, boscalid, prochloraz, and chlorothalonil provides synergistic control of selected fungi.Type: GrantFiled: October 6, 2010Date of Patent: November 11, 2014Assignee: Dow AgroSciences, LLC.Inventors: W. John Owen, Chenglin Yao
-
Patent number: 8877688Abstract: The present invention overcomes the inadequacies inherent in the known methods for generating libraries of antibody-encoding polynucleotides by specifically designing the libraries with directed sequence and length diversity. The libraries are designed to reflect the preimmune repertoire naturally created by the human immune system, with or without DH segments derived from other species, and are based on rational design informed by examination of publicly available databases of antibody sequences.Type: GrantFiled: March 13, 2009Date of Patent: November 4, 2014Assignee: Adimab, LLCInventors: Maximiliano Vasquez, Michael Feldhaus, Tillman U. Gerngross, K. Dane Wittrup
-
Patent number: 8741810Abstract: The present invention relates to a high efficiency method of expressing immunoglobulin molecules in eukaryotic cells. The invention is further drawn to a method of producing immunoglobulin heavy and light chain libraries, particularly using the trimolecular recombination method, for expression in eukaryotic cells. The invention further provides methods of selecting and screening for antigen-specific immunoglobulin molecules, and antigen-specific fragments thereof. The invention also provides kits for producing, screening and selecting antigen-specific immunoglobulin molecules. Finally, the invention provides immunoglobulin molecules, and antigen-specific fragments thereof, produced by the methods provided herein.Type: GrantFiled: August 17, 2007Date of Patent: June 3, 2014Assignee: University of RochesterInventors: Maurice Zauderer, Ernest S. Smith
-
Patent number: 8735330Abstract: The present invention provides an alternative scaffold for peptides displayed on filamentous phages through novel fusion proteins primarily originating from pVII. Libraries of filamentous phages can be created from fusion proteins, and a phage display system comprising a phagemid and a helper phage is a part of the invention. An aspect of the invention is a kit containing a phage display system comprising a phagemid and a helper phage that contains a nucleic acid encoding the fusion protein of the invention.Type: GrantFiled: August 20, 2008Date of Patent: May 27, 2014Assignee: Nextera ASInventor: Geir Åge Løset
-
Patent number: 8735329Abstract: The present invention provides methods for the prediction, prognosis and/or diagnosis of metastasis. The present invention also provides proteins (or the related nucleic acid sequences) or protein expression profiles which are predictive and/or prognostic for metastasis. The invention thus relates to the use of said proteins and the corresponding amino acid or nucleic acid sequences for the prediction, prognosis or diagnosis of metastasis.Type: GrantFiled: January 19, 2009Date of Patent: May 27, 2014Assignee: Katholieke Universiteit Leuven K.U. Leuven R&DInventors: Bart Landuyt, Liliane Schoofs, Walter Luyten
-
Patent number: 8685890Abstract: The invention relates to a method for providing a multispecific peptide ligand comprising a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues and capable of binding to two or more separate targets, comprising the steps of: (a) providing a first repertoire of polypeptides, each polypeptide comprising two or more reactive groups capable of covalent linkage to a molecular scaffold, and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; (b) providing a second repertoire of polypeptides as described in (a); (c) joining at least one loop of one or more members of the first repertoire to at least one loop of one or more members of the second repertoire to form at least one polypeptide comprising two loops, and (d) conjugating the composite polypeptide(s) to a molecular scaffold at at least three amino acid positions.Type: GrantFiled: February 4, 2010Date of Patent: April 1, 2014Assignee: Bicycle Therapeutics LimitedInventors: Gregory Paul Winter, Christian Heinis, Elise Bernard, David Loakes, John Tite, Marina Vaysburd, Daniel Paul Teufel, Lutz Riechmann
-
Patent number: 8603948Abstract: The present invention provides a novel, highly sensitive and specific probe panel which detects the type of renal cortical neoplasm present in a biopsy sample. As such, the invention permits diagnosis of the predominant subtypes of renal cortical neoplasms without the use of invasive methods. The present invention further provides a molecular cytogenetic method for detecting and analyzing the type of renal cortical neoplasm present in a renal biopsy sample.Type: GrantFiled: October 31, 2007Date of Patent: December 10, 2013Assignee: Cancer Genetics, Inc.Inventors: Raju S. K. Chaganti, Jane Houldsworth
-
Patent number: 7998672Abstract: Methods of performing PCR are provided. Methods may include using an optical source to provide heating for thermocyling the PCR reaction. Methods may include using surface plasmon resonance and/or fluorescence resonance enhanced transfer to allow real-time monitoring of a PCR reaction. Methods may include immobilizing a template, primer, or polymerase on a surface such as a gold or other surface plasmon resonance active surface.Type: GrantFiled: May 30, 2007Date of Patent: August 16, 2011Assignee: The University of Utah Research FoundationInventor: D. Keith Roper
-
Patent number: 7981600Abstract: Methods and devices for removing small negatively charged molecules from a biological sample mixture that uses an anion exchange material that has associated therewith a polyoxyalkylene.Type: GrantFiled: April 17, 2003Date of Patent: July 19, 2011Assignee: 3M Innovative Properties CompanyInventors: Ranjani V Parthasarathy, Rusty A. Rasmussen